| Issue |
Vis Cancer Med
Volume 3, 2022
|
|
|---|---|---|
| Article Number | E1 | |
| Number of page(s) | 3 | |
| DOI | https://doi.org/10.1051/vcm/2022003 | |
| Published online | 26 April 2022 | |
Supplementary material
Video 1: The video shows the dynamic response to the HAIC-FO therapy of the patient mentioned in Figure 1. After six cycles of treatment, the size of the lesions shrunk by more than 90% (strong partial response). The patient’s disease was downstaged from advanced to early stage and treated with locally imaging-guided thermal ablation by the investigator’s team. During a follow-up period of 49.9 months, there was no evidence of disease progression from the radiology imaging. HAIC-FO, interventional hepatic arterial infusion chemotherapy of FOLFOX regimens.
Download Video: Formats: mp4 (6.3 MB) | webm (685.0 KB) | ogg (15.3 MB) | Original mp4 (6.3 MB)
© The Authors, published by EDP Sciences, 2022
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.